WeVote

Bill

Bill

LB 887

Change provisions relating to pharmacists and transfer of prescriptions and eliminate a report under the Parkinson's Disease Registry Act

109th Legislature (2025-2026) Introduced by Bob Hallstrom

LB 887 expands pharmacist prescription transfer authority in Nebraska while eliminating state Parkinson's Disease Registry reporting requirements.

Notice of hearing for January 22, 2026
0
WeVote Research Nonpartisan
Bill Summary · LB 887

Legislative bill overview

LB 887 modifies Nebraska's regulations governing pharmacists' authority to transfer prescriptions between pharmacies and eliminates an ongoing reporting requirement under the state's Parkinson's Disease Registry Act. The bill streamlines pharmacist practices while reducing administrative burden on health agencies.

Why is this important

Prescription transfer rules directly affect patient convenience and medication access continuity—particularly for chronic disease management. Eliminating the Parkinson's registry report reduces government administrative costs but may affect disease surveillance and public health data collection for a specific health condition.

Potential points of contention

  • Patient access vs. pharmacy burden: Expanded pharmacist transfer authority could improve medication access but may create liability or inventory management challenges for smaller pharmacies
  • Public health data loss: Eliminating the Parkinson's registry report removes systematic disease tracking that could inform treatment patterns, resource allocation, and health planning
  • Scope of practice: Changes to pharmacist authority represent an ongoing debate about expanding clinical roles versus traditional dispensing functions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.